Sravan Kumar Emany sold $45k of IRWD
SVP, COO and CFO at IRONWOOD PHARMACEUTICALS INC. 11,001 shares at an average of $4.08, traded Nov 18, 2024, filed Nov 20, 2024.
Score components
- +22RoleCFO
- +6Trade size$45k at market
- 0Share of holdings soldSold 3.4% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +26.4%, 3m -44.9%, 6m -83.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-129227, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | SOpen-market sale Class A Common Stock | -11,001 | $4.08 | $45k | 309,572 | Nov 20, 2024 |
Related signals
Other insiders at IRONWOOD PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | IRWDsell IRONWOOD PHARMACEUTICALS INC | Alexander J Denner director | $21M 6,730,800 shares | -42% | |
| 24Weak | IRWDsell IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $80k 21,526 shares | -9% | |
| 15Weak | IRWDsell IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $20k 6,016 shares | -2% | |
| 30Weak | IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $1,105 1,316 shares | -1% | |
| 37Weak | IRONWOOD PHARMACEUTICALS INC | Gregory S. Martini Chief Financial Officer | $1,063 1,265 shares | -1% | |
| 30Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver Principal Accounting Officer | $2,391 2,846 shares | -1% | |
| 30Weak | IRONWOOD PHARMACEUTICALS INC | Minardo John Chief Legal Officer | $6,513 7,754 shares | -2% | |
| 23Weak | IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $1,487 2,563 shares | -1% | |
| 33Weak | IRONWOOD PHARMACEUTICALS INC | Thomas A MCCOURT Chief Executive Officer | $7,745 13,353 shares | -1% | |
| 37Weak | IRONWOOD PHARMACEUTICALS INC | Gregory S. Martini Chief Financial Officer | $21k 12,052 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.